Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes.

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Type 2 diabetes (T2D) involves impaired glucose homeostasis due to insulin resistance or beta-cell dysfunction.
• Complex etiology includes obesity, lifestyle, genetics, and environmental factors.
• Noncoding RNAs (ncRNAs) are emerging as key players in T2D pathophysiology.

Purpose of the Study:

• To review the role of ncRNAs, particularly miRNAs and lncRNAs, in T2D pathogenesis.
• To discuss the impact of genetic variations in ncRNAs on T2D development.
• To highlight ncRNAs involved in beta-cell function and insulin sensitivity.

Main Methods:

• Literature review of studies on ncRNAs in T2D.
• Focus on microRNAs (miRNAs) regulating beta-cell function and insulin action.
• Examination of long noncoding RNAs (lncRNAs) in pancreatic islets.

Main Results:

• ncRNAs, including miRNAs, are implicated in insulin-sensitive tissues (pancreas, liver, muscle, adipose).
• Polymorphisms in ncRNAs or their targets represent a novel class of genetic variation in T2D.
• lncRNAs show potential to contribute to beta-cell dysfunction under hyperglycemia.

Conclusions:

• ncRNAs are critical regulators in T2D pathogenesis.
• Genetic variations in ncRNAs are significant contributors to T2D susceptibility.
• Further research into lncRNAs in pancreatic islets is warranted.